PTC Therapeutics | PTCT - Marktkapitalisierung

Aktienkurs
65.30
Täglich Wechseln
-1.78 -2.65%
Monatlich
-7.38%
Jährlich
14.28%
Q1 Prognose
63.34




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Cytokinetics USD 7.77B 1.19B 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 475M 410M 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Novartis USD 240.48B 51.73B 2026-03
Pfizer USD 153.96B 12.4B 2026-03
PTC Therapeutics USD 6.1B 1.22B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Xencor USD 1.09B 256M 2025-12